Evidence map›Paper›PMID 37349361›Full record

ArticleNPJ vaccines2023

Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.

Julian Sohl, Ann-Kathrin Hartmann, Jennifer Hahlbrock, Joschka Bartneck, Michael Stassen, Matthias Klein, Matthias Bros, Stephan Grabbe, Federico Marini, Kevin Woods and 8 more

Abstract readPublished Erratum
In one paragraph

Article in NPJ vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Julian SohlIIIrd Department of Medicine - Hematology & Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Ann-Kathrin HartmannIIIrd Department of Medicine - Hematology & Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Jennifer HahlbrockInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Joschka BartneckIIIrd Department of Medicine - Hematology & Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Michael StassenInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Matthias KleinInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Matthias BrosResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Stephan GrabbeResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Federico MariniResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.ORCID http://orcid.org/0000-0003-3252-7758
Kevin WoodsIIIrd Department of Medicine - Hematology & Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Borhane GuezguezIIIrd Department of Medicine - Hematology & Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.ORCID http://orcid.org/0000-0002-1474-8074
Matthias MackDepartment of Nephrology, University Hospital Regensburg, Regensburg, Germany.ORCID http://orcid.org/0000-0002-3157-7262
Hansjörg SchildInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Sabine MuthInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Felix MelchiorInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.ORCID http://orcid.org/0000-0002-7113-9857
Hans Christian ProbstInstitute of Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Peter LangguthResearch Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Markus P RadsakIIIrd Department of Medicine - Hematology & Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. radsak@uni-mainz.de.ORCID http://orcid.org/0000-0002-3991-5721

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37349361
PMCPMC10287714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.